OTRUSVYQUE Trademark

Trademark Overview


On Wednesday, August 10, 2022, a trademark application was filed for OTRUSVYQUE with the United States Patent and Trademark Office. The USPTO has given the OTRUSVYQUE trademark a serial number of 97542596. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2024. This trademark is owned by Glaxo Group Limited. The OTRUSVYQUE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
otrusvyque

General Information


Serial Number97542596
Word MarkOTRUSVYQUE
Filing DateWednesday, August 10, 2022
Status700 - REGISTERED
Status DateTuesday, June 18, 2024
Registration Number7417114
Registration DateTuesday, June 18, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 30, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Saturday, August 13, 2022NEW APPLICATION ENTERED
Tuesday, August 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 26, 2023ASSIGNED TO EXAMINER
Tuesday, May 30, 2023SUSPENSION LETTER WRITTEN
Tuesday, May 30, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, May 30, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 27, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 10, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, February 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 18, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED